Skip to Content
 
Center for International Blood and Marrow Transplant Research

MM19-03

Main Content

Second autologous stem cell transplantation as salvage therapy for relapsed or refractory immunoglobulin light chain amyloidosis.

Study #: MM19-03

Study Status: Published

A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients.

Citation

Tan CR, Estrada-Merly N, Landau H, Lekakis L, Banerjee R, Mian H, Usmani SZ, Hanbali A, Lazarus HM, Kyle RA, Dholaria B, Bal S, Strouse C, Murthy HS, Wirk B, Nishihori T, Kumar S, Shah N, Qazilbash M, D'Souza A.

Bone Marrow Transplantation. 2022, Feb 01: 57(2): 57(2):295-298. doi: 10.1038/s41409-021-01527-z. Epub 2021, Nov 20. PMCID:PMC8825695.

PubMed

PMID: 34802047

Abstract